HIV-enhancing factors are secreted by reproductive epithelia upon inoculation with bacterial vaginosis-associated bacteria

Protein and Peptide Letters

Volumn 22, Issue 8, 2015, Pages 672-680

  Eade, Colleen R ^a   Diaz, Camila ^b   Chen, Sixue ^c   Cole, Amy L ^b   Cole, Alexander M ^b  

^a Cornell University ^*  (United States)

^b UNIVERSITY OF CENTRAL FLORIDA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

Atopobium vaginae; Bacterial vaginosis; Female reproductive tract; Heterosexual HIV transmission; Innate immunity; Mucosal immunology

Indexed keywords

CELL PROTEIN; CYCLOPHILIN A; HE4 PROTEIN; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; TRAPPIN 2 PROTEIN; UNCLASSIFIED DRUG; ACUTE PHASE PROTEIN; LCN2 PROTEIN, HUMAN; LIPOCALIN; ONCOPROTEIN; PI3 PROTEIN, HUMAN; PROTEIN; TIPRELESTAT; WFDC2 PROTEIN, HUMAN;

ARTICLE; ATOPOBIUM VAGINAE; BACTERIUM CULTURE; BIOASSAY; CELL CULTURE; CELL VIABILITY; CELLULAR SECRETION; COCULTURE; DISEASE ASSOCIATION; HOST PATHOGEN INTERACTION; HOST RESISTANCE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOBLOTTING; INFECTION SENSITIVITY; INOCULATION; MASS SPECTROMETRY; MOLECULAR WEIGHT; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN FUNCTION; PROTEIN SECRETION; UPREGULATION; UTERINE CERVIX EPITHELIUM; VAGINITIS; ACTINOBACTERIA; CELL LINE; CYTOLOGY; DISEASE PREDISPOSITION; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; INNATE IMMUNITY; MICROBIOLOGY; MUCOSA; PATHOGENICITY; PHYSIOLOGY; SECRETION (PROCESS); UTERINE CERVIX; VIROLOGY;

ATOPOBIUM VAGINAE; BACTERIA (MICROORGANISMS);

ACTINOBACTERIA; ACUTE-PHASE PROTEINS; CELL LINE; CERVIX UTERI; CYCLOPHILIN A; DISEASE SUSCEPTIBILITY; ELAFIN; FEMALE; HIV INFECTIONS; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; LIPOCALIN-2; LIPOCALINS; MUCOUS MEMBRANE; PROTEINS; PROTO-ONCOGENE PROTEINS; UP-REGULATION; VAGINOSIS, BACTERIAL;

EID: 84938771972     PISSN: 09298665     EISSN: 18755305     Source Type: Journal    
DOI: 10.2174/0929866522666150309155735     Document Type: Article

References (28)

1. Sobel, J. D. Bacterial Vaginosis. Annu. Rev. Med., 2000, 51, 349-56.
2. Koumans, E. H.; Sternberg, M.; Bruce, C.; McQuillan, G.; Kendrick, J.; Sutton, M.; Markowitz, L. E. The prevalence of bacterial vaginosis in the United States, 2001-2004; associations with symptoms, sexual behaviors, and reproductive health. Sex. Transm. Dis., 2007, 34, 864-69.
3. Martin, H. L.; Richardson, B. A.; Nyange, P. M.; Lavreys, L.; Hillier, S. L.; Chohan, B.; Mandaliya, K.; Ndinya-Achola, J. O.; Bwayo, J.; Kreiss, J. Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J. Infect. Dis., 1999, 180, 1863-8.
4. Atashili, J.; Poole, C.; Ndumbe, P. M.; Adimora, A. A.; Smith, J. S. Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS, 2008, 22, 1493-501.
5. Wira, C. R.; Grant-Tschudy, K. S.; Crane-Godreau, M. A. Epithelial cells in the female reproductive tract: a central role as sentinels of immune protection. Am. J. Reprod. Immunol., 2005, 53, 65-76.
6. Wira, C. R.; Patel, M. V.; Ghosh, M.; Mukura, L.; Fahey, J. V. Innate Immunity in the Human Female Reproductive Tract: Endocrine Regulation of Endogenous Antimicrobial Protection Against HIV and Other Sexually Transmitted Infections. Am. J. Reprod. Immunol., 2011, 65, 196-211.
7. Cole, A. M.; Cole, A. L. Antimicrobial polypeptides are key anti-HIV-1 effector molecules of cervicovaginal host defense. Am. J. Reprod. Immunol., 2008, 59, 27-34.
8. Shukair, S. A.; Allen, S. A.; Cianci, G. C.; Stieh, D. J.; Anderson, M. R.; Baig, S. M.; Gioia, C. J.; Spongberg, E. J.; Kauffman, S. M.; McRaven, M. D.; Lakougna, H. Y.; Hammond, C.; Kiser, P. F.; Hope, T. J. Human cervicovaginal mucus contains an activity that hinders HIV-1 movement. Mucosal Immunol., 2013, 6, 427-34.
9. Quayle, A. J.; Porter, E. M.; Nussbaum, A. A.; Wang, Y. M.; Brabec, C.; Yip, K. P.; Mok, S. C. Gene expression, immunolocalization, and secretion of human defensin-5 in human female reproductive tract. Am. J. Pathol., 1998, 152, 1247-58.
10. Fan, S. R.; Liu, X. P.; Liao, Q. P. Human defensins and cytokines in vaginal lavage fluid of women with bacterial vaginosis. Int. J. Gynaecol. Obstet., 2008, 103, 50-4.
11. King, A. E.; Critchley, H. O.; Kelly, R. W. Presence of secretory leukocyte protease inhibitor in human endometrium and first trimester decidua suggests an antibacterial protective role. Mol. Hum. Reprod., 2000, 6, 191-6.
12. King, A. E.; Critchley, H. O.; Sallenave, J. M.; Kelly, R. W. Elafin in human endometrium: an anti-protease and anti-microbial molecule expressed during menstruation. J. Clin. Endocrinol. Metab., 2003, 88, 4426-31.
13. Venkataraman, N.; Cole, A. L.; Svoboda, P.; Pohl, J.; Cole, A. M. Cationic polypeptides are required for anti-HIV-1 activity of human vaginal fluid. J. Immunol., 2005, 175, 7560-7.
14. Fazeli, A.; Bruce, C.; Anumba, D. O. Characterization of Toll-like receptors in the female reproductive tract in humans. Hum. Reprod., 2005, 20, 1372-8.
15. Akira, S.; Takeda, K. Toll-like receptor signalling. Nat. Rev. Immunol., 2004, 4, 499-511.
16. Eade, C. R.; Diaz, C.; Wood, M. P.; Anastos, K.; Patterson, B. K.; Gupta, P.; Cole, A. L.; Cole, A. M. Identification and characterization of bacterial vaginosis-associated pathogens using a comprehensive cervical-vaginal epithelial coculture assay. PLoS ONE, 2012, 7, e50106.
17. Osborn, L.; Kunkel, S.; Nabel, G. J. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc. Natl. Acad. Sci. USA, 1989, 86, 2336-40.
18. Bradshaw, C. S.; Tabrizi, S. N.; Fairley, C. K.; Morton, A. N.; Rudland, E.; Garland, S. M. The association of Atopobium vaginae and Gardnerella vaginalis with bacterial vaginosis and recurrence after oral metronidazole therapy. J. Infect. Dis., 2006, 194, 828-836.
19. Ferris, M. J.; Masztal, A.; Aldridge, K. E.; Fortenberry, J. D.; Fidel, P. L. Jr; Martin, D. H. Association of Atopobium vaginae, a recently described metronidazole resistant anaerobe, with bacterial vaginosis. BMC Infect. Dis., 2004, 4, 5.
20. Libby, E. K.; Pascal, K. E.; Mordechai, E.; Adelson, M. E.; Trama, J. P. Atopobium vaginae triggers an innate immune response in an in vitro model of bacterial vaginosis. Microbes Infect., 2008, 10, 439-446.
21. Klotman, M. E.; Rapista, A.; Teleshova, N.; Micsenyi, A.; Jarvis, G. A.; Lu, W.; Porter, E.; Chang, T. L. Neisseria gonorrhoeaeinduced human defensins 5 and 6 increase HIV infectivity: role in enhanced transmission. J. Immunol., 2008, 180, 6176-85.
22. Zegels, G.; Van Raemdonck, G. A.; Coen, E. P.; Tjalma, W. A.; Van Ostade, X. W. Comprehensive proteomic analysis of human cervicalvaginal fluid using colposcopy samples. Proteome Sci., 2009, 7, 17.
23. Pushkarsky, T.; Zybarth, G.; Dubrovsky, L.; Yurchenko, V.; Tang, H.; Guo H.; Toole, B.; Sherry, B.; Bukrinsky, M. CD147 facilitates HIV-1 infection by interacting with virus-associated cyclophilin A. Proc. Natl. Acad. Sci. USA, 2001, 98, 6360-5.
24. Durum, S. K.; Schmidt, J. A.; Oppenheim, J. J. Interleukin 1: an immunological perspective. Annu. Rev. Immunol., 1985, 3, 263-87.
25. Harada, A.; Sekido, N.; Akahoshi, T.; Wada, T.; Mukaida, N.; Matsushima, K. Essential involvement of interleukin-8 IL-8 in acute inflammation. J. Leukocyte Biol., 1994, 56, 559-64.
26. Krueger, J.; Ray, A.; Tamm, I.; Sehgal, P. B. Expression and function of interleukin-6 in epithelial cells. J. Cell Biochem., 1991, 45, 327-34.
27. Ghosh, M.; Shen, Z.; Fahey, J. V.; Cu-Uvin, S.; Mayer, K.; Wira, C. R. Trappin-2/Elafin: a novel innate anti-human immunodeficiency virus-1 molecule of the human female reproductive tract. Immunology, 2010, 129, 207-19.
28. Drannik, A. G.; Nag, K.; Yao, X. D.; Henrick, B. M.; Jain S.; Ball, T. B.; Plummer, F. A.; Wachihi, C.; Kimani, J.; Rosenthal, K. L. Anti-HIV-1 activity of elafin is more potent than its precursor's, trappin-2, in genital epithelial cells. J. Virol., 2012, 86, 4599-610.